Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis

Clinical Cancer Research

Volumn 14, Issue 10, 2008, Pages 2978-2987

  Reddy, Sreekanth P ^a   Britto, Ramona ^b   Vinnakota, Katyayni ^a   Aparna, Hebbar ^a   Sreepathi, Hari Kishore ^c   Thota, Balaram ^e   Kumari, Arpana ^b   Shilpa, B M ^e   MVrinda, ^e   Umesh, Srikantha ^e   Samuel, Cini ^d   Shetty, Mitesh ^d   Tandon, Ashwani ^e   Pandey, Paritosh ^e   Hegde, Sridevi ^d   Hegde, A S ^f   Balasubramaniam, Anandh ^e   Chandramouli, B A ^e   Santosh, Vani ^e   Kondaiah, Paturu ^a   Somasundaram, Kumaravel ^b,c   Rao, M R Satyanarayana ^c,g   more..

^a Departments Ofmolecular Reproduction Development and Genetics   (India)

^b Department of Microbblogy and Cell Biology ^*  (India)

^c INDIAN INSTITUTE OF SCIENCE   (India)

^d MANIPAL HOSPITAL   (India)

^e NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^f SRI SATHYA SAI INSTITUTE OF HIGHER MEDICAL SCIENCES   (India)

^g JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE ENHANCER BINDING PROTEIN 1; FOLLISTATIN; FOLLISTATIN LIKE 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; MANGANESE SUPEROXIDE DISMUTASE; TRANSCRIPTOME; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BRAIN TUMOR; DNA MICROARRAY; GENETICS; KAPLAN MEIER METHOD; MORTALITY;

BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 49649087701     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4821     Document Type: Article

References (37)

1. Santiago P, Silbergeld DL Malignant gliomas: anaplastic astrocytoma, glioblastoma multiforme, gliosar-coma, malignant oligodendroglioma. In: Winn HR, editor. Youman's neurological surgery. Philadelphia: Saunders; 2004. p. 969-80.
2. LeglerJM, Ries LA, Smith MA, et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers-recent trends in incidence and mortality. J Natl Cancer lnst1999;91:1382-90.
3. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999;1:44-51.
4. Kleihues P, Burger PC, Collins VP, Ohgaki H, Cavenee WK. Glioblastoma. In: Kleihues P, Cavenee WK, editors. Pathology and genetics of tumors of nervous system. Lyon: IARC Press; 2000. p. 29-39.
5. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002:61:215-25; discussion 26-9.
6. Liang Y Diehn M.Watson N, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA 2005;102:5814-9.
7. van den Boom J, Wolter M, Kuick R, et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003;163:1033-43.
8. Somasundaram K, Reddy SP, Vinnakota K, et al. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. Oncogene 2005;24:7073-83.
9. Saeed Al, Sharov V, White J, et al.TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003;34:374-8.
10. Tusher VG. Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
11. Louis DN, Ohgaki HO.WiestlerOD, Cavenee WK, editors. WHO classification of tumors of the central nervous system. 4th ed. Lyon (France): IARC Press; 2007.
12. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190-8.
13. Kapoor GS, O'Rourke DM. Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches. Cancer Biol Ther 2003;2:330-42.
14. Louis DN, Holland EC, Cairncross JG. Glioma classification: a molecular reappraisal. Am J Pathol 2001;159:779-86.
15. Newcomb EW, Cohen H, Lee SR, et al. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol 1998;8:655-67.
16. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004;64:6892-9.
17. Rainov NG, Dobberstein KU, Bahn H, et al. Prognostic factors in malignant glioma: influence of the over-expression of oncogene and tumor-suppressor gene products on survival. J Neurooncol 1997;35:13-28.
18. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003;63:1602-7.
19. Carrier F, Smith ML, Bae I, et al. Characterization of human Gadd45, a p53-regulated protein. J Biol Chem 1994;269:32672-7.
20. Takekawa M, Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 1998;95:521-30.
21. Yamasawa K, Nio Y, Dong M.Yamaguchi K, Itakura M. Clinicopathological significance of abnormalities in Gadd45 expression and its relationship top53 in human pancreatic cancer. Clin Cancer Res 2002;8:2563-9.
22. Sheikh MS, Hollander MC, Fornance AJ, Jr. Role of Gadd45 in apoptosis. Biochem. Pharmacol 2000;59: 43-5.
23. Bulavin DV, Kovalsky O, Hollander MC, Fornace AJ, Jr. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol Cell Biol 2003;23:3859-71.
24. Liebermann DA, Hoffman B. Blood Cells Mol Dis 2007;39:329-35.
25. Tanaka M, Ozaki S, Kawabata D, et al. Potential preventive effects of follistatin-related protein/TSC-36 on joint destruction and antagonistic modulation of its autoantibodies in rheumatoid arthritis. Int Immunol 2003;15:71-7.
26. Shibanuma M, MashimoJ, Mita A, Kuroki T, Nose K. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-β, 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem 1993;217:13-9.
27. Ohashi T, Sato S, Yoshiki A, Kusakabe M. TSC-36 (follistatin-related polypeptide) gene expression in estrogen receptor positive osteoblastic cell line, CD07F. Calcif Tissue Int 1997;61:400-3.
28. Sumitomo K, Kurisaki A, Yamakawa N, et al. Expression of aTGF-β1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines. Cancer Lett 2000;155:37-46.
29. Liu S, Wang L, Wang W, et al. TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration. Exp Mol Pathol 2006;80:132-40.
30. Trojan L, Schaaf A, Steidler A, et al. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res 2005;25:183-91.
31. Razanajaona D, Joguet S, Ay AS, et al. Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth. Cancer Res 2007;67:7223-9.
32. Kim KH, Rodriguez AM, Carrico PM, Melendez JA. Potential mechanisms for the inhibition of tumor cell growth by manganese superoxide dismutase. Anti-oxid Redox Signal 2001;3:361-73.
33. Malafa M, Margenthaler J, Webb B, Neitzel L, Christophersen M. MnSOD expression is increased in metastatic gastric cancer. J Surg Res 2000;88:130-4.
34. Nelson KK, Ranganathan AC, Mansouri J, et al. Elevated sod2 activity augments matrix metalloprotei- nase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 2003;9:424-32.
35. He GP, Muise A, Li AW, Ro HS. A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature 1995;378:92-6.
36. Ro HS, Zhang L, Majdalawieh A, et al. Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis. Obesity (Silver Spring) 2007;15:288-302.
37. Zhang L, Reidy SP, Nicholson TE, et al. The role of AEBP1 in sex-specific diet-induced obesity. Mol Med 2005;11:39-47.